An Overview Of Brain Stimulation Therapies
Archives
All entries, chronologically...
A hormone derived from visceral fat called adiponectin may play a role as a risk factor for development of all-cause dementia and Alzheimer disease (AD) in women, according to a study published Online First by the Archives of Neurology, one of the JAMA/Archives journals. The study was completed by Thomas M. van Himbergen, Ph.D., from the Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging, Tufts University, Boston, and colleagues.
New research suggests that, in people who do not currently have memory problems, those with smaller regions of the brain’s cortex may be more likely to develop symptoms consistent with very early Alzheimer’s disease. The study is published in the December 21, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
Patients with Parkinson disease-related dementia appear to have increased brain atrophy in the hippocampal, temporal and parietal lobes and decreased prefrontal cortex volume compared to patients with Parkinson disease without dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archivesjournals. The study was conducted by Daniel Weintraub, M.D., of the Perelman School of Medicine, University of Pennsylvania, Philadelphia, and colleagues.
Depression is one of the most common mental disorders in the elderly, but little is known about the underlying biology of its development in older adults. In a small study published in the November issue of the peer-reviewed journal Archives of General Psychiatry, UCLA researchers used a unique brain scan to assess the levels of amyloid plaques and tau tangles in older adults with a type of severe depression called major depressive disorder (MDD).
Family caregivers of people with dementia experience more burden and are at greater risk of developing depression than caregivers of people with a chronic illness. A new evidence review from the Netherlands finds that a psychotherapy technique called cognitive reframing can help reduce caregivers’ stress when they are caring for loved ones with dementia.
People who rate their health as poor or fair appear to be significantly more likely to develop dementia later in life, according to a study published in the October 5, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and obsessive-compulsive disorder, these medications are effective for only a few off-label conditions, and that the benefits and harms of these medications for these uses vary, according to an article in the September 28 issue of JAMA.
Any exercise that gets the heart pumping may reduce the risk of dementia and slow the condition’s progression once it starts, reported a Mayo Clinic study published this month in Mayo Clinic Proceedings. Researchers examined the role of aerobic exercise in preserving cognitive abilities and concluded that it should not be overlooked as an important therapy against dementia.
People with high cholesterol may have a higher risk of developing Alzheimer’s disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.
Improving and maintaining health factors not traditionally associated with dementia, such as denture fit, vision, and hearing, may lower a person’s risk for developing dementia, according to a new study published in the July 13, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology. The lead study author was Kenneth Rockwood, MD, of Dalhousie University in Halifax, Nova Scotia, Canada.
